4月 2026Medisafe的市場佔有率分析

Medisafe is the leading medication engagement platform that empowers patients to seamlessly manage their treatment journey. We engage one patient at a time, but at scale, guided through our advanced technology to build a future model of patient support with clinically validated results.

健康 > 健康 - 其他

域名medisafe.com

成立年份2012

僱員51 - 200

年度營收$10M - $15M

Medisafe

Medisafe（包含公司地區）

medisafe.com

查看更多網站流量與參與度資訊

Medisafe截至 4月 2026 的總收入為 10M - 15M

Medisafe 熱門網域產生的總收入

Medisafe 熱門網域 3 年內的總收入

Medisafe 熱門網域的總收入

medisafe.com10M - 15M

透過銷售情報查看更多內容

Medisafe的熱門網域總造訪量

了解Medisafe市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

medisafe.com42.9K

透過銷售情報查看更多內容

Medisafe的熱門網域平均造訪時長

分析Medisafe參與度指標。

過去 3 個月平均造訪時長

子公司細目

medisafe.com00:00:22

透過銷售情報查看更多內容

Medisafe的熱門網域平均頁面瀏覽量

了解Medisafe如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

medisafe.com1.57

透過銷售情報查看更多內容

Medisafe按網域劃分的熱門競爭對手

4月 2026的熱門類似網站，依相似度排名

medminder.com公司名MedMinder僱員51 - 200總部美國, 馬薩諸塞州, Norwood年度營收$15M - $25M訪問總量8.4K健康 > 老年護理

使用的熱門技術Medisafe

这些是Medisafe顶级域名使用的行业网站技术

付費廣告 (11)

Google Adsense

付款與貨幣 (5)

Visa

社群 (5)

Instagram

小工具 (5)

Twemoji

更多技術

13

檢視所有

新聞與訊號來自Medisafe

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Medisafe Project Ltd. launched mandatory premium subscription for most core features on Jan 1st '26.In January 2026, Medisafe introduced a mandatory premium subscription for most core features.

新聞Medisafe Project Ltd. recognized as Best Care Coordination Platform" at 9th annual MedTech Breakthrough Awards program on May 27th '25.NUTLEY, N.J., May 27, 2025 - MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market, announced that Eisai Inc., Biogen and Medisafe, have been awarded the "Best Care Coordination Platform" for the PATHWAYS tool in the 9th annual MedTech Breakthrough Awards program.

新聞Medisafe Project Ltd. launched GOMEKLI Digital Companion on May 13th '25.BOSTON, MA / May 13, 2025 / Medisafe, the leading digital health platform for medication engagement, today announced a collaboration with SpringWorks Therapeutics to launch the GOMEKLI(TM)(mirdametinib) Digital Companion by Medisafe - an innovative, behaviorally driven platform designed to support GOMEKLI patients living with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas (NF1-PN).